Entera Bio Ltd.
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
-3.558
Price/Sales ratio
0.751.01
Earnings per Share (EPS)
$-0.54$0.24

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-17.44-44.90-4.80-2.35-2.38-1.99-6.04-1.60-1.954.24-2.37
Price/Sales ratio
N/AN/AN/A48.52110.1454.49129.06156.93N/A105.3982.31
Price/Book Value ratio
-2.90-2.13-1.702.392.182.983.261.781.672.202.28
Price/Cash Flow ratio
-21.37-17.13-11.89-2.47-2.91-1.90-8.13-1.68-2.38-1.28-2.69
Price/Free Cash Flow ratio
-21.05-16.91-11.76-2.45-2.90-1.89-8.11-1.67-2.37-1.28-2.68
Price/Earnings Growth ratio
N/A0.73-0.003.080.070.040.460.370.06-0.390.06
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A100%11.01%42.73%34.67%24.62%N/A23.57%17.29%
Operating Profit Margin
N/AN/AN/A-2172.20%-4853.38%-3050.13%-2139.57%-9714.17%N/A-8191.86%-3951.76%
Pretax Profit Margin
N/AN/AN/A-2060.8%-4574.15%-2729.58%-2144.65%-9652.23%N/A2420.32%-3317.47%
Net Profit Margin
N/AN/AN/A-2060.8%-4609.74%-2735.06%-2134.32%-9754.47%N/A2480.48%-3335.27%
Effective Tax Rate
N/AN/A1.30%-5.40%-0.77%-0.20%0.48%-1.05%-0.32%2.11%-3.09%
Return on Assets
-155.87%-19.07%-84.32%-77.23%-65.13%-97.28%-46.89%-99.57%-75.55%46.48%-71.18%
Return On Equity
16.66%4.74%35.48%-101.85%-91.27%-149.78%-54.00%-111.20%-85.58%38.69%-96.56%
Return on Capital Employed
-190.47%126.10%100.75%-94.01%-94.57%-159.29%-53.52%-110.44%-83.29%-170.98%-126.93%
Liquidity Ratios
Current Ratio
N/AN/AN/A6.973.402.78N/AN/AN/A9.585.18
Quick Ratio
2.360.516.146.893.382.818.019.8010.319.365.14
Cash ratio
1.490.395.814.193.302.627.879.1710.099.173.75
Days of Sales Outstanding
N/AN/AN/A529.25429.95255116.97670.07N/A365397.47
Days of Inventory outstanding
N/AN/AN/AN/A132.09-162.41N/A-1.06KN/AN/A-15.16
Operating Cycle
N/AN/AN/AN/A562.0592.58116.97-392.40N/A90327.31
Days of Payables Outstanding
4.57K552.715.05KN/A580.52286.41162.4361.43540.9833.00433.46
Cash Conversion Cycle
N/AN/AN/AN/A-18.47-193.82-45.46-453.83N/A331.99156.76
Debt Ratios
Debt Ratio
7.684.090.29N/A0.010.040.010.000.030.100.06
Debt Equity Ratio
-0.82-1.02-0.12N/A0.020.060.010.000.030.110.01
Long-term Debt to Capitalization
-4.61-1.69-0.14N/A0.010.030.00N/A0.02N/A0.02
Total Debt to Capitalization
-4.6150.99-0.14N/A0.020.060.010.000.03N/A0.04
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-193.76N/A
Cash Flow to Debt Ratio
-0.16-0.12-1.16N/A-29.82-24.12-30.00-137.35-18.74N/A-14.91
Company Equity Multiplier
-0.10-0.24-0.421.311.401.531.151.111.131.111.47
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A-19.59-37.79-28.55-15.87-93.27N/A-81.78-33.17
Free Cash Flow / Operating Cash Flow Ratio
1.011.011.011.001.001.001.001.001.001.001.00
Cash Flow Coverage Ratio
-0.16-0.12-1.16N/A-29.82-24.12-30.00-137.35-18.74N/A-14.91
Short Term Coverage Ratio
N/A-0.31N/AN/A-50.38-55.14-50.63-137.35-54.55-221.07-52.76
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A